MRSsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2025-03-03
Share capital
5 000,00 PLN
Registered address
ul. Kazimierza Siemienowicza 8, 01-481 Warszawa, Poland
Electronic delivery address
AE:PL-44828-15151-SUVBU-30
Financials
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 321.66kMedianUSD 133.41kAverageUSD 14.85m
Net profit
This companyUSD 124.84kMedianUSD -1.58AverageUSD -42.14m
Operating costs
This companyUSD 196.04kMedianUSD 173.70kAverageUSD 50.05m
Assets
This companyUSD 169.78kMedianUSD 249.90kAverageUSD 83.06m
Industry
Bank accounts
Registered as a VAT taxpayer on 2025-03-08. Active
51 1140 2004 0000 3802 7864 4260
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
2 tenders recorded as contractor, with a total value of $1,314,588.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 11, 2026 | Świadczenie usług polegających na wykonaniu zadań powierzonych przez Sponsora związanych z realizacją niekomercyjnego badania klinicznego (nefryt) w dwóch ośrodkach – Instytutu Matki i Dziecka oraz Państwowego Instytutu Medycznego Ministerstwa Spraw Wewnętrznych i Administracji, wraz z przygotowaniem, konfiguracją, udostępnieniem systemu Elektronicznej Karty Obserwacji Klinicznej eCRF (...) | $686.4K$686,386 | Instytut Matki i Dziecka | |
| Dec 1, 2025 | „Świadczenie usług polegających na wykonaniu zadań powierzonych przez Sponsora związanych z realizacją niekomercyjnego badania klinicznego (dragonfly) w dwóch ośrodkach – Klinice Onkologii i Chirurgii Onkologicznej Dzieci i Młodzieży Instytutu Matki i Dziecka i Klinice Nowotworów Tkanek Miękkich, Kości i Czerniaków, Narodowego Instytutu Onkologii (...)" | $628.2K$628,202 | Instytut Matki i Dziecka |
Authorized Representatives
Anna Maria Jelitto – President of the Management Board
Izabela Sztajneker – Management Board Member
Manner of representation
Each member of the management board may represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Anna Maria Jelitto (39) | 50 | $675.31 | 50% |
Izabela Sztajneker (69) | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Anna Maria Jelitto (39)  | Shareholder of a limited liability company, 2500.0 PLN | |
Izabela Sztajneker (69) | Shareholder of a limited liability company, 2500.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com |
FAQ
Last updated: 2026-10-07